Compound information
- Natural Products
- ZC250770
- Molecular Formula
- C21H30N4O5S
- Molecular Weight
- 450.19369106 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-morpholinosulfonylphenyl)propanamide
- InChI
- InChI=1S/C21H30N4O5S/c1-16(23-8-10-24(11-9-23)21(27)17-2-3-17)20(26)22-18-4-6-19(7-5-18)31(28,29)25-12-14-30-15-13-25/h4-7,16-17H,2-3,8-15H2,1H3,(H,22,26)/t16-/m0/s1
- InChI Key
- KTVVSMSGEPQRFO-INIZCTEOSA-N
- SMILES
- C[C@@H](C(=O)Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)N1CCN(C(=O)C2CC2)CC1
- Source
- ZINC000014018264
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 4 |
Heteroatom Count | 10 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 99.26 Å2 | LogP | 0.655 |
LogS | -2.636 | LogD | 1.288 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.011 | Pgp substrate | 0.979 |
HIA | 0.97 | F20 % | 0.99 |
F30 % | 0.746 | Caco-2 | -4.846 |
MDCK | -5.307 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.038 | PPB | 80.986 |
VD | 1.135 | Fu | 0.428 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.451 |
CYP2A6 substrate | 0.61 | CYP2B6 substrate | 0.699 |
CYP2C19 inhibitor | 0.329 | CYP2C19 substrate | 0.825 |
CYP2C8 substrate | 0.636 | CYP2C9 inhibitor | 0.106 |
CYP2C9 substrate | 0.921 | CYP2D6 inhibitor | 0.014 |
CYP2D6 substrate | 0.906 | CYP2E1 substrate | 0.209 |
CYP3A4 inhibitor | 0.034 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.198 | CL | 4.991 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.201 | Hepatotoxicity | 0.629 |
Mutagenicity | 0.008 | Rat Oral Acute Toxicity | 0.196 |
FDAMDD | 0.443 | Skin Sensitization | 0.041 |
Carcinogenicity | 0.271 | Eye Corrosion | 0.004 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.188 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.023 | IGC50 | 1.937 |
LC50FM | -20.988 | LC50DM | -3.977 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.264 | NR-AR-LBD | 0.38 |
NR-AhR | 0.072 | NR-Aromatase | 0.054 |
NR-ER | 0.205 | NR-ER-LBD | 0.402 |
NR-PPAR-gamma | 0.115 | SR-ARE | 0.37 |
SR-ATAD5 | 0.301 | SR-HSE | 0.085 |
SR-MMP | 0.012 | SR-p53 | 0.105 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.